Found: 18
Select item for more details and to access through your institution.
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect.
- Published in:
- Journal of NeuroVirology, 2013, v. 19, n. 4, p. 383, doi. 10.1007/s13365-013-0190-x
- By:
- Publication type:
- Article
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 6, p. 730, doi. 10.1164/rccm.202112-2836OC
- By:
- Publication type:
- Article
Visceral and subcutaneous adiposity measurements in adults: influence of measurement site.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 9, p. 1945, doi. 10.1002/jbmr.3183
- By:
- Publication type:
- Article
Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 6, p. 1264, doi. 10.1002/jbmr.1861
- By:
- Publication type:
- Article
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 3, p. 671, doi. 10.1093/infdis/jiad446
- By:
- Publication type:
- Article
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Health Utility Estimates and Their Application to HIV Prevention in the United States: Implications for Cost-Effectiveness Modeling and Future Research Needs.
- Published in:
- MDM Policy & Practice, 2020, v. 5, n. 2, p. 1, doi. 10.1177/2381468320936219
- By:
- Publication type:
- Article
Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 4, p. N.PAG, doi. 10.1093/ofid/ofx262
- By:
- Publication type:
- Article
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
- Published in:
- Clinical Trials, 2022, v. 19, n. 1, p. 52, doi. 10.1177/17407745211049829
- By:
- Publication type:
- Article
How to construct an optimal interim report:What the data monitoring committee does and doesn't need to know.
- Published in:
- Clinical Trials, 2018, v. 15, n. 4, p. 359, doi. 10.1177/1740774518764449
- By:
- Publication type:
- Article
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. S5, doi. 10.1177/1740774512440342
- By:
- Publication type:
- Article
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 3, p. 420, doi. 10.1093/cid/ciy051
- By:
- Publication type:
- Article
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155100
- By:
- Publication type:
- Article